Piracetam and other nootropes, glycine, polyamines and some structure analoges of putrescine are considered in the present review as the regulating cerebroprotectors. They differ from competitive and non-competitive blockers of the ionotropic glutamate receptors, which are neuroprotectors also, by ability both enhance and depotentiate the function of glutamate synapses in a dose-dependent manner.
